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Abstract
Background: Obstetric hemorrhage is the leading cause of maternal mortality globally. The Non-pneumatic Anti-
Shock Garment (NASG) is a low-technology, first-aid compression device which, when added to standard
hypovolemic shock protocols, may improve outcomes for women with hypovolemic shock secondary to obstetric
hemorrhage in tertiary facilities in low-resource settings.
Methods: This study employed a pre-intervention/intervention design in four facilities in Nigeria and two in Egypt.
Primary outcomes were measured mean and median blood loss, severe end-organ failure morbidity (renal failure,
pulmonary failure, cardiac failure, or CNS dysfunctions), mortality, and emergency hysterectomy for 1442 women
with ≥750 mL blood loss and at least one sign of hemodynamic instability. Comparisons of outcomes by study
phase were assessed with rank sum tests, relative risks (RR), number needed to treat for benefit (NNTb), and
multiple logistic regression.
Results: Women in the NASG phase (n = 835) were in worse condition on study entry, 38.5% with mean arterial
pressure <60 mmHg vs. 29.9% in the pre-intervention phase (p = 0.001). Despite this, negative outcomes were
significantly reduced in the NASG phase: mean measured blood loss decreased from 444 mL to 240 mL (p <
0.001), maternal mortality decreased from 6.3% to 3.5% (RR 0.56, 95% CI 0.35-0.89), severe morbidities from 3.7% to
0.7% (RR 0.20, 95% CI 0.08-0.50), and emergency hysterectomy from 8.9% to 4.0% (RR 0.44, 0.23-0.86). In multiple
logistic regression, there was a 55% reduced odds of mortality during the NASG phase (aOR 0.45, 0.27-0.77). The
NNTb to prevent either mortality or severe morbidity was 18 (12-36).
Conclusion: Adding the NASG to standard shock and hemorrhage management may significantly improve
maternal outcomes from hypovolemic shock secondary to obstetric hemorrhage at tertiary care facilities in low-
resource settings.
Background
Obstetric hemorrhage is the leading cause of maternal
mortality globally. In low-resource settings, delays in
identifying hemorrhage, delays in transport to facilities
from a home birth or from primary care centers, and
delays in receiving definitive therapies upon arrival at
tertiary facilities contribute to high rates of maternal
mortality and morbidity secondary to hypovolemic
shock [1]. Access to definitive therapies, such as blood
transfusions and surgery, necessary to manage severe
hypovolemia, is limited to major medical centers (ter-
tiary facilities), which are often located in large cities.
Even in advanced university teaching hospitals, there
may be hours of delay awaiting blood transfusions, there
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bank, and/or a lack of blood donors. In the absence of
hemodynamic stability provided by those transfusions,
anesthetists and surgeons (if they are available) will not
consider performing necessary hemostatic surgery.
Further, in some settings, if the woman is eligible for
surgery, it is more feasible to perform an emergency
hysterectomy than the more time and skill intensive
devascularization. A woman may unnecessarily lose her
uterus and suffer infertility, which in certain cultures
may lead to divorce and increasing poverty. In a 2003
Bellagio meeting on the problem of maternal mortality
and morbidity due to hemorrhage, experts suggested
trying anti-shock garments (ASG) for stabilization to
help women survive delays [2].
Results from the use of the Non-pneumatic Anti-
Shock Garment (NASG) (Zoex Corporation, Ashland,
OR) to stabilize women with obstetric hemorrhage have
been published in a case series, a pilot study, and two
small comparative studies [3-7]. The NASG is a low-
technology, first-aid device that delivers circumferential
counter pressure to the lower body, legs, pelvis, and
abdomen (Figure 1). Made of neoprene and Velcro™,
with a foam compression ball that is placed over the
abdomen, the NASG can be applied by anyone who has
received training. Unlike the Pneumatic Anti-Shock
Garment (PASG or medical anti-shock trousers MAST),
previously used in the U.S. for pre-hospital trauma first-
aid, there are no manometers, stop cocks or inflation
devices; pressures applied by the NASG do not exceed
70 mmHg, thus avoiding potential ischemia or compart-
ment syndrome. The mechanisms of action include
applying circumferential counter pressure which
decreases the container size; blood flow is decreased in
the compressed area (abdomen, pelvis, lower extremi-
ties) while blood flow to the uncompressed area (core
organs) is enhanced. Further, compression decreases the
radius of the blood vessels in the abdomen and pelvis,
including the splanchnic plexus, which decreases blood
flow. More detailed information about the NASG has
been published elsewhere [5-9].
We conducted non-randomized pre-intervention/
intervention studies in four tertiary care facilities in
Nigeria from March 2004 - December 2007 and in two
tertiary facilities in Egypt from June 2006 - May 2008.
The following analysis combines data from these facil-
ities, which had equivalent pre-intervention and NASG
data collection periods. The objective of this analysis is
to examine whether adding the NASG to the standard
protocol for managing hypovolemic shock secondary to
obstetric hemorrhage of any etiology would improve
maternal outcomes at the tertiary care level. While we
have previously published the outcomes of interim ana-
lyses of a small (n = 169) study at one of the Nigerian
facilities [7] and a larger one in Egypt (n = 990) [5],
being able to combine the data from the two studies
that were methodologically similar (using the same clini-
cal diagnoses, protocol, and outcomes) allows us to be
able to conduct more rigorous, robust regression ana-
lyses on a rare outcome: maternal mortality.
Methods
The studies were approved by Institutional Review
Boards at the University of California, San Francisco
(UCSF), the National Reproductive Health Research
Committee of the Nigerian Federal Ministry of Health,
the El Galaa Maternity Teaching Hospital and Assiut
University Women’s Health Center.
The four sites selected from Nigeria were tertiary level
teaching facilities, with 1,250-10,000 deliveries annually.
The eight other facilities that were included in the pro-
ject in Nigeria were implementation/intervention sites
only and did not have a pre-intervention phase; there-
fore their data were not used in this analysis. The sites
in Egypt comprised two tertiary teaching facilities,
which had combined 31,990 deliveries in the pre-
intervention and 31,176 deliveries in the NASG phase.
The methods of the studies have been described in
more detail elsewhere [5,7]. Briefly, in both countries,
non-randomized intervention studies with a pre-inter-
vention phase for controls were conducted. Women
with hypovolemic shock secondary to obstetric hemor-
rhage from any etiology were eligible for enrollment if
they had an estimated blood loss of ≥750 mL and one
or more clinical signs of hypovolemic shock (systolic
blood pressure [SBP] <100 mmHg and/or pulse >100
beats per minute [BPM]). Women were eligible regard-
less if they began to hemorrhage outside the facility and
were transferred in, or began to hemorrhage in the facil-
ity. All etiologies of obstetric or pregnancy-related
Figure 1 The NASG being applied.
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Page 2 of 8hemorrhage were included: complications of abortion,
ectopic pregnancy, trophoblastic disease of pregnancy,
problems of placentation, ruptured uterus, abruption,
uterine atony, and lacerations. Women with ante-
partum hemorrhage >24 weeks with a living fetus (based
on presence of fetal heart tones) were excluded.
During the pre-intervention phase in all facilities,
women were managed with a standardized, evidence-
based hemorrhage and shock protocol [5]; the interven-
tion phase included the NASG into this protocol. The
standardized protocol for both phases included: admin-
istration of oxygen, IV crystalloid fluids (>1500 mL in
the first hour), and establishing the etiology of the
hemorrhage. If the hemorrhage was due to uterine
atony, uterotonics were administered, including: oxyto-
cin, methergine, and misoprostol, and uterine massage
or bimanual compression was performed. Depending on
the source of the bleeding, the protocol included repair
of lacerations, vaginal procedures such as manual
vacuum aspiration or curettage to remove retained pro-
ducts and manual removal of retained placenta. Explora-
tory laparotomy was conducted and procedures
performed, such as a salpingectomy for a ruptured ecto-
pic, repair of a ruptured uterus, or an emergency hyster-
ectomy. The protocol included laboratory investigations,
such as complete blood count, creatinine, type and cross
matching, and tests to rule out coagulopathies. Urine
output was measured using either a Foley to a calibrated
drainage bag or a straight catheter to a graduated collec-
tion bottle. Finally, the protocol called for a blood trans-
fusion for all women with signs of shock.
Blood loss after study entry in both phases was mea-
sured using a closed-end, calibrated, plastic blood col-
lection drape (BRASSS-V Fixable Drape™ Madurai,
India). If the woman required a vaginal procedure, the
NASG was left completely in place. If she required a
laparotomy, the abdominal and pelvic segments were
opened immediately prior to making the incision, and
then replaced when the surgery was completed. Staff in
the facilities were trained in the standardized protocol,
blood collection and measurement, NASG use, and
completion of data collection forms.
Definitions: For the purpose of the study, mortality
refers to the death of a woman who was pregnant,
post-partum or post abortion within the period of time
of hospitalization for hemorrhage. Following the defini-
tion by Mantel et al. [10] severe maternal morbidities
were defined as organ system dysfunctions related to
severe obstetric hemorrhage: acute respiratory distress
syndrome (impairment of respiratory function needing
ventilation, oxygen supplementation or decreased phy-
sical activity level as compared to pre-pregnancy), cer-
ebral impairment (seizures, unconsciousness, or
cognitive/motor loss), renal failure (creatinine >1.5
mg/dL or increased >1.0 mg/dL above baseline, oli-
guria; <120 mL output in 4-hour intervals) and heart
failure (impairment of cardiac function according to
New York Heart Disease Classification [11]). The
severity of the woman’s condition at study admission
was calculated by her mean arterial pressure (MAP);
t h o s ew i t hM A P< 6 0w e r ei nm o r es e v e r ec o n d i t i o n .
The formula for MAP is [2*diastolic blood pressure +
systolic blood pressure]/3 [12].
Treatment variables included adherence to the clinical
protocol of administering >1500 mL crystalloid fluids in
the first hour after study admission, administration of
blood transfusions, and administration of uterotonics for
uterine atony. Outcomes of the study were mortality,
severe end-organ dysfunction morbidity, measured
blood loss, and emergency hysterectomy for uterine
atony cases.
Paper and pen data collection forms were completed
by trained clinician/data collectors at the time of treat-
ment or shortly after. Data supervisors in each country
reviewed the data forms for completeness and accuracy.
Data forms were sent to the University of California,
San Francisco (UCSF), entered into a Microsoft Access
database (Microsoft, Redmond, WA, USA), checked for
errors and inconsistencies and analyzed. In Egypt, the
paper forms were sent electronically to UCSF through a
data fax system (Clinical DataFax Systems Inc., Ontario,
Canada).
Data Analysis: The analysis used combined data from
the four largest Nigerian tertiary facilities (n = 452) and
from two facilities in Egypt (n = 990); the total sample
for analysis was 1442. The demographic characteristics,
condition on study entry and treatment received for
women in the two study phases were compared using
two-sided t-tests of differences in the means of continu-
ous variables (assuming unequal variances in the two
study phase populations); the Wilcoxon rank sum test
was used for non-normally distributed continuous vari-
ables (normality was tested using qnorm and sktest in
Stata.), and chi-square tests of independence were used
for dichotomous variables (with Fisher’s exact tests used
where required).
Relative risks (RR) with 95% confidence intervals were
computed for the primary outcomes, mortality and
severe maternal morbidity, and for the secondary out-
come of emergency hysterectomy (for cases of primary
or secondary diagnosis of uterine atony). From the RRs,
we calculated the number needed to treat for benefit
(NNTb) to prevent each of these outcomes, including
an NNTb to prevent a case of either mortality or mor-
bidity. An additional secondary outcome, the volume of
measured blood loss in the drape (mL), was compared
across study phases with the Wilcoxon rank sum test.
To estimate the independent effect of the NASG
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while controlling for other characteristics, we fitted a
multiple logistic regression model for each of the two
outcomes.
The independent variables included in the two models,
in addition to study phase, were selected on the basis of
their significant associations with the outcomes in
bivariate analyses. These were severity of shock (MAP
<60); parity (0-4 vs. 5 or more live births); primary defi-
nitive diagnosis of uterine atony vs. another diagnosis;
and whether the woman began bleeding outside the
facility or not (for the morbidity model only, as this
variable was not significantly associated with mortality
in bivariate analysis). In addition, facility was included
as a control variable in order to hold constant the effect
(on the outcomes) of any unmeasured systematic differ-
ences in the characteristics of the six clinical popula-
tions or in the quality of care provided in the six
settings. We anticipated violations of the independent
and identically distributed (I.I.D.) assumption in the
data because of clustering at the facility level, which
would cause standard errors in the regression models to
be biased; therefore, we used robust standard errors
(using vce (robust) post estimation command for logistic
regression in Stata) to address this problem. The confi-
dence level for all tests was set to 95%. Data were ana-
lyzed using Stata/SE (version 10).
Written informed consent was obtained for publica-
tion of the figure.
Results
There were 1,442 women with hypovolemic shock
entered into the study, 607 in the pre-intervention
phase and 835 in the NASG phase. There were no sig-
nificant differences in demographic characteristics
(Table 1). There were a variety of etiologies, with signifi-
cantly more ectopic pregnancy, ruptured uterus and pla-
centa previa during the pre-intervention phase and
more uterine atony, complications of abortion and
lacerations during the NASG phase. During the pre-
intervention phase significantly more women entered
the study who had started bleeding at home/other facil-
ity vs. began bleeding in the hospital (p < 0.001). How-
ever, women in the NASG phase were in worse
condition on study entry, with 38.5% (n = 321) with
MAP <60 compared to 29.9% (n = 181) in the pre-inter-
vention phase. Treatment variables (Table 2) show sig-
nificantly fewer women in the NASG phase receiving
either >1500 mL crystalloid fluids or a blood transfusion
in the first hour (p < 0.001). However, by the end of the
second hour after study admission, n = 531 (87.5%) in
the pre-intervention phase and n = 723 (86.6%) had
received the protocol (p = 0.62). The median time to
initiation of the first blood transfusion, 35 minutes pre-
intervention compared to 33 minutes NASG phase, was
not significantly different.
Outcomes were better for the women in the NASG
phase (Table 3). Measured mean and median volumes
of blood loss after study entry were lower, medians were
400 mL in the pre-intervention phase vs. 200 mL NASG
phase (p < 0.001). Emergency hysterectomies for intract-
able uterine atony were reduced by 56%, from 8.9% (n =
2 0 )p r e - i n t e r v e n t i o nt o4 . 0 %( n=1 4 )i nt h eN A S G
phase (RR 0.44, 95% CI 0.23-0.86). Severe morbidities
were decreased by 81%, with 3.7% (n = 21) experiencing
end-organ dysfunction in the pre-intervention phase vs.
0.7% (n = 6) in the NASG phase (RR 0.20, 95% CI 0.08-
0.50) and mortalities were reduced by 44%, 6.3%
(n = 38) died in the pre-intervention while only 3.5%
(n = 29) died during the NASG phase (RR 0.56, 95% CI
0.35-0.89). The NNTb to avoid an adverse outcome was
also computed from the RR statistics [13], for the fol-
lowing outcomes: the NNTb to prevent maternal mor-
tality was 36, (95% CI 20-202), the NNTb to prevent
one severe morbidity was 34 (95% CI 22-78). For
women with a diagnosis of uterine atony, the NNTb to
prevent one emergency hysterectomy was 20 (95% CI
11-138). To prevent one extreme adverse outcome,
combining mortality and severe maternal morbidity, the
NNTb was 18 (95% CI 12-36). (Data not shown)
The results of the multiple logistic regression analysis
are shown in Table 4, with the left column of the table
denoting findings for the model with mortality as the
dependent variable, and the right column showing find-
ings for the morbidity model. As shown, women with a
MAP <60 mmHg had over eight times the odds of mor-
tality (aOR 8.42, 95% CI 3.13-22.66) relative to those
with MAP ≥60 mmHg. No other control variables (par-
ity, primary diagnosis or facility) were significantly asso-
ciated with mortality, but the NASG intervention was
associated with 55% lower odds of mortality (aOR 0.45,
95% CI 0.27-0.77). In the model of factors associated
with severe maternal morbidity, women with a MAP
<60 mmHg had almost five times the odds of morbidity
(aOR 4.83, 1.80-12.94) relative to those with MAP ≥60
mmHg. Those with a parity of 5 or more had 2.4 times
the odds of morbidity (aOR 2.43, 1.06-5.58), but both
where bleeding began and facility were not associated
with the outcome. The NASG intervention was signifi-
cantly associated with 80% lower odds of morbidity
(aOR 0.20, 95% CI 0.07-0.56).
Because the odds of morbidity and of mortality were
so strikingly high for women with MAP <60, indepen-
dent of the study phase, we also conducted a stratified
analysis by severity of condition (MAP <60 vs. MAP
≥60) for each of the two outcomes, using the same
model specification from Table 4. An ameliorative effect
of the intervention for reduced morbidity was seen in
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Page 4 of 8Table 1 Demographics, diagnoses, and condition on entry to study (N = 1442)
Pre-intervention N = 607 NASG N = 835 p value
Study sites
Egypt (2 referral hospitals) 432 558 –
Nigeria (4 referral hospitals) 175 277 –
Demographic characteristics
Age: Mean years of age (SD) 29.0 (6.4) 29.3 (6.2) 0.27
Median age (IQR) 28 (25-33) 29 (25-35) –
Parity: Mean live births (SD) 3.2 (2.8) 3.3 (2.8) –
Median parity (IQR) 2 (1-5) 3 (1-5) 0.18
Pregnancy duration: Mean weeks (SD)* 37.0 (4.1) 37.4 (3.6) –
Median weeks (IQR) 38 (36-40) 38 (36-40) 0.18
Primary definitive diagnosis
Uterine atony 190 (33.0) 319 (38.2) 0.007
Ectopic pregnancy 95 (15.7) 85 (10.2) 0.002
Complications of abortion 45 (7.4) 93 (11.1) 0.02
Abruption of placenta 79 (13.0) 98 (11.7) 0.47
Vaginal, cervical or genital lacerations 25 (4.1) 65 (7.8) 0.004
Retained placenta or tissue 71 (11.7) 83 (9.9) 0.29
Ruptured uterus 46 (7.6) 32 (3.8) 0.002
Placenta previa 40 (6.6) 31 (3.7) 0.01
Placenta accrete 6 (1.0) 9 (1.1) 1.000√
Molar pregnancy 7 (1.2) 11 (1.3) 1.000√
Condition on study entry
Where hemorrhage began <0.001
Transferred in bleeding 382 (72.9) 333 (56.4)
Began bleeding in hospital 142 (27.1) 258 (43.6)
Estimated revealed blood loss at study entry
+
Mean mL (SD) 1210.0 (507.7) 1327.5 (480.7) –
Median mL (IQR) 1000 (1000-1500) 1200 (1000-1500) <.0001
Women with MAP < 60 or non-palpable BP
‡ 181 (29.9) 321 (38.5) 0.001
NASG = Non-pneumatic Anti-Shock Garment. Data are n (column %), mean (SD) or median (IQR). The denominator is the entire population, unless otherwise
noted. Tests of significance of differences by study phase were chi-square for categorical variables, t-tests (assuming unequal variances) for normally-distributed
continuous variables and Wilcoxon rank-sum tests for non-normal distributions.
*Excludes abortion, ectopic and molar pregnancies.
√Fisher’s Exact test used.
+Data missing for 250 patients.
‡MAP < 60 category includes those with non-palpable blood pressure (BP). Data missing for 2 patients.
Table 2 Treatments for shock and hemorrhage administered during two study phases (N = 1442)
Treatment Pre-intervention N = 607 NASG N = 835 p value
Any uterotonics administered* 217 (96.9) 345 (97.7) 0.60
+
≥1500 mL IV fluids within 1st hour
‡ 491 (81.2) 548 (65.6) <0.001
≥1500 mL IV fluids within 2nd hour 531 (87.5) 723 (86.6) 0.62
Blood transfusion within 1
st hour 438 (72.2) 509 (61.0) <0.001
Blood transfusion anytime after study admission 566 (93.3) 785 (94.0) 0.56
Minutes from study admission to 1
st blood transfusion
§
Mean (SD) 119.1 (326.7) 117.5 (281.5) –
Median (IQR) 35 (29-59) 33 (28-110) 0.48
NASG = non-pneumatic anti-shock garment. Data are n (column%). The denominator is the entire population, unless otherwise noted.
*Of women with uterine atony as primary or secondary diagnosis. Data are for 578 cases.
+Fisher’s Exact test used.
‡The protocol was for 1500 mL to be administered in the first hour of resuscitation, however, in some cases only 1000 mL were administered in the first hour,
while the remaining 500 mL were administered in the second hour. By the end of the second hour after study admission, n = 531 (87.5%) in the pre-intervention
phase and n = 723 (86.6%) had received the protocol.
§Data for 104 patients missing (39 pre-intervention and 65 in intervention phase).
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0.80), and MAP ≥60 (aOR 0.18, 95% CI 0.04-0.90). For
the stratified mortality model, the NASG intervention
was significantly associated with a reduced odds of
death in women with MAP <60 (aOR 0.46, 95% CI 0.26-
0.80), but not in women with MAP ≥60 (aOR 0.68, 95%
CI 0.14-3.22). (Data not shown)
Discussion
In these six tertiary care facilities in Nigeria and Egypt,
women with hypovolemic shock secondary to obstetric
hemorrhage treated with standard protocol plus the NASG
had improved outcomes, despite being in worse condition
on study entry than those in the pre-intervention phase.
The results of multiple logistic regression modeling of
the independent associations of the NASG with mortal-
ity and morbidity respectively, suggest that the NASG
intervention shows promise for reducing the incidence
of extreme adverse outcomes in women with hypovole-
mic shock secondary to obstetric hemorrhage. The con-
cern motivating our stratified analysis of factors
associated with morbidity and mortality by MAP group-
ing was to determine if the intervention was only effec-
tive in women in less severe shock; the findings
underscored the NASG’s association with reduced mor-
bidity and mortality even in women with MAP <60, and
supports the intervention’s potential efficacy. The lower
rates for mortality and severe morbidity among women
Table 3 Outcomes between standard hemorrhage and shock management (pre-intervention) and standard
management plus NASG (intervention) (N = 1442)
Outcome Pre-intervention (N = 607) NASG (N = 835) Relative Risk (95%CI) P value NNTb
Measured vaginal blood loss in drape:
Mean mL (SD)* 443.5 (346.1) 240.0 (199.4) –
Median mL (IQR) 400 (250-500) 200 (150-250) <0.0001
Emergency hysterectomy
+ 20 (8.9) 14 (4.0) 0.44 (0.23-0.86) – 20 (11-138)
Morbidity
‡ 21 (3.7) 6 (0.7) 0.20 (0.08-0.50) – 34 (22-78)
Mortality 38 (6.3) 29 (3.5) 0.56 (0.35-0.89) – 36 (20-202)
NASG = Non-pneumatic Anti-Shock Garment. Data are n (%) or mean (SD). The denominator is the entire population, unless otherwise noted.
*For cases in which the calibrated blood collection drape was used and there were data for blood loss. Wilcoxon rank-sum test used to compare distributions by
study phase. Data are for 1005 cases.
+Data on emergency hysterectomy are only for women with primary or secondary diagnosis of uterine atony (n = 578).
‡Includes renal failure, acute respiratory distress syndrome, heart failure, cerebral impairment (seizures, un-consciousness, motor/cognitive loss) lasting more than
24 hours after resuscitation from shock. Denominator is the number of women who survived (n = 1375).
Table 4 Multiple logistic regression models of factors predictive of mortality and morbidity
Factor Dependent variable: mortality Dependent variable: morbidity
aOR p 95% CI aOR p 95% CI
Severity of shock
MAP < 60 (or non-palpable BP) 8.42 <0.001 3.13 22.66 4.83 0.002 1.80 12.94
MAP 60 or higher 1 1
Parity
5 or more live births 1.33 0.35 0.73 2.42 2.43 0.04 1.06 5.58
0-4 live births 1 1
Primary Diagnosis
Uterine atony 1.44 0.19 0.83 2.49 2.68 0.07 0.93 7.76
Other condition 1 1
Where bleeding began*
Transferred in bleeding –– – – 1.82 0.51 0.30 10.93
Began bleeding at RH –– – – 1
Study Phase
NASG 0.45 0.004 0.27 0.77 0.20 0.002 0.07 0.56
Pre-intervention 1 1
NASG = Non-pneumatic Anti-Shock Garment. aOR = adjusted odds ratio. Reference groups for categorical variables shown in italics. Hospital facility included as
control variable in both models, but not shown in Table 4. The number of observations in Table 4 is less than 1442 because of missing data; n = 1038 for the
morbidity model, and n = 1442 for the mortality model. Robust standard errors used to adjust for clustering at the facility level.
*Where bleeding began was not a significant predictor of mortality, but it was associated with morbidity, in bivariate analysis. Therefore it is included in the
multiple logistic regression model of factors predictive of morbidity only.
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for that variable.
An interesting finding among this large sample of
women with severe hemorrhage is the relatively low
rates of uterine atony. While the contribution of uterine
atony to complications of pregnancy and maternal mor-
tality have been described as anywhere from 40-70%
[14,15], in this study where only women suffering severe
hemorrhage and shock were entered, uterine atony
accounted for less than 40% of the sample. This study
b e g a nb e f o r et h ep r a c t i c eo ft h eA c t i v eM a n a g e m e n to f
Third Stage Labor (AMTSL) was well established in
either country, so it is possible that as AMTSL becomes
more widely practiced, uterine atony will be seen as
contributing even less to maternal mortality from obste-
tric hemorrhage. Nearly all the women with uterine
atony in both phases received uterotonics for treatment.
In terms of outcomes, significantly fewer women in the
NASG phase underwent emergency hysterectomy for
u t e r i n ea t o n y ,w h i c hm a yb ea t t r i b u t a b l et ot h el a c ko f
panic among providers who were caring for women
with decreased bleeding and stable vital signs. A recently
published sub-analysis of 854 women from the com-
bined Egypt and Nigeria dataset, all of whom had a PPH
diagnosis, revealed similar findings to the obstetric
hemorrhage outcomes shown here, with a mortality
decrease from 9% pre-intervention to 3.1% in the NASG
phase (RR 0.35, 95% CI 0.19-0.62) [16].
It is also interesting to note the worse condition of the
w o m e no ns t u d ye n t r yi n t ot h eN A S Gp h a s e .W e
believe that this was due to the clinician/data collectors
h e s i t a n c yt op u to nt h eN A S Gu n t i lt h ew o m a nw a s
severely compromised, given that the NASG was a new
technology, and the clinicians had not yet incorporated
it into their emergency response repertoire. They may
have delayed putting it on until it was clear that the
women really needed it. While an alternative explana-
tion could be that the women became more ill during
the time the NASG was applied, it is unlikely, given that
the NASG can be applied in less than 3 minutes.
Another finding, the lower rate of women receiving the
correct volume of IV fluids for shock resuscitation, may
have been due to a developed complacency after placing
w o m e ni nt h eN A S G .O n c et h ew o m a n ,r e g a r d l e s so f
her state of shock, is placed in the NASG, the response
is seen almost immediately: the pulse slows, the BP
rises, the woman regains consciousness, and the bleed-
ing diminishes. It may be that clinicians seeing this
response to placement of the NASG may have been less
anxious. If this is the case, it means that training must
be modified to stress that all women with hypovolemic
shock need the same immediate standard resuscitation,
and that placement of the NASG is supportive of, but
does not replace the need for IV fluids, blood, and other
hemorrhage and shock management. While NASG use
decreases mortality, women still die with the NASG,
particularly if there are major delays in supplying blood
[17].
There are limitations inherent in the pre-post study
design. The effect of time and experience managing
women in hypovolemic shock could have improved over
time, as the intervention succeeded the pre-intervention.
Selection bias is always a risk in a non-randomized trial,
where not every patient in a facility is enrolled. It may
have been that there were patients who were not
enrolled despite meeting entry criteria. Given the large
number of patients in each facility and the lack of staff-
ing, some patients’ data may not have been entered.
Another limitation to this study was that there was an
imbalance between patients based on both etiology of
hemorrhage and on where patients began bleeding.
More patients in the NASG phase had uterine atony,
while more patients in the pre-intervention phase began
bleeding outside the facility. In bivariate analysis, where
bleeding began was not significantly associated with
mortality, but it was associated with morbidity; however,
it did not remain significantly associated with morbidity
in the multiple logistic regression model. Uterine atony
diagnosis was associated with both adverse outcomes in
bivariate analyses, but the association did not remain
statistically significant in either of the multiple logistic
regression models.
There are limitations to the applicability of these find-
ings to the real world of maternal mortality and morbid-
ity due to obstetric hemorrhage in low-resource settings.
With the majority of the world’s women delivering out-
side of tertiary facilities and without skilled attendants,
there may be greater implications for public health in a
study conducted outside the tertiary care level. A rando-
mized trial with women entered into the study at per-
ipheral levels is now being conducted in Africa (http://
www.clinicaltrials.gov: NCT00488462).
Conclusions
Obstetric hemorrhage is the leading cause of maternal
mortality globally, particularly in low-resource settings
where long delays contribute to adverse outcomes that
would not occur in higher resource settings. The use of
the NASG, a low-technology, circumferential counter
pressure first-aid device, appears to mitigate the effect
of the delays. More rigorous research is warranted to
better understand the potential of this device.
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